AU2001248173A1 - Use of uric acid or precursors thereof as a treatment for cancer, aids and the like - Google Patents

Use of uric acid or precursors thereof as a treatment for cancer, aids and the like

Info

Publication number
AU2001248173A1
AU2001248173A1 AU2001248173A AU4817301A AU2001248173A1 AU 2001248173 A1 AU2001248173 A1 AU 2001248173A1 AU 2001248173 A AU2001248173 A AU 2001248173A AU 4817301 A AU4817301 A AU 4817301A AU 2001248173 A1 AU2001248173 A1 AU 2001248173A1
Authority
AU
Australia
Prior art keywords
precursors
aids
cancer
treatment
uric acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001248173A
Inventor
Roman Rozencwaig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2001248173A1 publication Critical patent/AU2001248173A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU2001248173A 2000-04-07 2001-04-04 Use of uric acid or precursors thereof as a treatment for cancer, aids and the like Abandoned AU2001248173A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CA002304869A CA2304869A1 (en) 2000-04-07 2000-04-07 Method of medical treatment using uric acid or precursors thereof
CA2,304,869 2000-04-07
PCT/CA2001/000457 WO2001076606A2 (en) 2000-04-07 2001-04-04 Use of uric acid or precursors thereof as a treatment for cancer, aids and the like

Publications (1)

Publication Number Publication Date
AU2001248173A1 true AU2001248173A1 (en) 2001-10-23

Family

ID=4165836

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001248173A Abandoned AU2001248173A1 (en) 2000-04-07 2001-04-04 Use of uric acid or precursors thereof as a treatment for cancer, aids and the like

Country Status (3)

Country Link
AU (1) AU2001248173A1 (en)
CA (1) CA2304869A1 (en)
WO (1) WO2001076606A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5508031A (en) * 1986-11-21 1996-04-16 Cetus Oncology Corporation Method for treating biological damage using a free-radial scavenger and interleukin-2
WO1997039352A1 (en) * 1996-04-15 1997-10-23 Fox Chase Cancer Center Assays for detection of purine metabolites
US5872124A (en) * 1996-07-31 1999-02-16 Thomas Jefferson University Treatment of diseases of the central nervous system using uric acid as a scavenger of peroxynitrite
CA2339004C (en) * 1998-07-31 2008-04-01 Hme Enterprises, Llc Antioxidant composition and method of treating diseases using same

Also Published As

Publication number Publication date
CA2304869A1 (en) 2001-10-07
WO2001076606A2 (en) 2001-10-18
WO2001076606A3 (en) 2002-08-01

Similar Documents

Publication Publication Date Title
AU2002223827A1 (en) Well treatment
AU2001265253A1 (en) Treatment of hiv using hyperthermia
AU2002213887A1 (en) Process for the antimicrobial treatment of fiber materials
AU2001269704A1 (en) Oxazinoquinolones useful for the treatment of viral infections
AU2002231206A1 (en) Treatment of depression
AU2001260834A1 (en) The treatment of herpes
AU2002322481A1 (en) Use of r-nsaid compounds for anti-hiv treatment
AU2001293891A1 (en) New combination for the treatment of asthma
AU2021601A (en) Composition for the treatment of dandruff
AU2001245414A1 (en) Treatment of allergies
AU2003291368A1 (en) Compounds for the treatment of tobacco dependence and withdrawal
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001248173A1 (en) Use of uric acid or precursors thereof as a treatment for cancer, aids and the like
AU2003295163A1 (en) Composition for the treatment of hiv or aids
AU7756900A (en) Treatment of chemical hydrolysates
AU5824800A (en) Use of fosphenytoin for the treatment of acute neuropathic pain
AU1618901A (en) Treatment of rosacea
MXPA03004454A (en) Imidazolone derivatives for the treatment of viral diseases.
AU2001281465A1 (en) Treatment of rosacea
AU2001282277A1 (en) Treatment of mycobacterial infection
AU2003238414A1 (en) Use of diuretics for treating swellings
AU2001253560A1 (en) Methods of treatment
EP1177789A3 (en) Use of phytanic acid for the treatment of diabetes
AU2000272704A1 (en) Use of compounds for the treatment of obesity
AU2178999A (en) Preparation of methacrylic acid, derivatives thereof or precursors thereto